Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€3.84
07.12.21
€5.00
07.12.22
-19.79%
08.12.22

Could be worthwhile Investment >10% per year
buy
Craneware plc

Start price
Target price
Perf. (%)
€27.40
07.12.21
€32.00
07.12.22
-13.14%
07.12.22

Could be worthwhile Investment >10% per year
Innovative
Some uniques
Future proof or reliable business model
buy
Seelos Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.90
13.07.22
-
03.08.24
21.71%
06.12.22

buy
Hybrigenics S.A.

Start price
Target price
Perf. (%)
€0.12
03.12.21
€0.25
03.12.22
-46.60%
04.12.22

Could be worthwhile Investment >10% per year
buy
Oncopeptides AB

Start price
Target price
Perf. (%)
€1.02
02.12.21
€1.50
02.12.22
56.67%
03.12.22

Could be worthwhile Investment >10% per year
buy
Theradiag S.A.

Start price
Target price
Perf. (%)
€2.16
02.12.21
€2.80
02.12.22
4.86%
03.12.22

Could be worthwhile Investment >10% per year
buy
C4x Discovery Holdings plc

Start price
Target price
Perf. (%)
€0.49
02.12.21
-
02.12.22
-53.06%
03.12.22

Could be worthwhile Investment >10% per year
buy
E-Therapeutics Plc

Start price
Target price
Perf. (%)
€0.49
02.12.21
-
02.12.22
-48.98%
03.12.22

Could be worthwhile Investment >10% per year
buy
Vivoryon Therapeutics N.V.

Start price
Target price
Perf. (%)
€18.36
27.11.21
€19.00
27.11.22
-50.44%
28.11.22

Could be worthwhile Investment >10% per year
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€4.80
14.11.22
-
14.11.23
-13.88%
28.11.22

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
Oncopeptides AB

Start price
Target price
Perf. (%)
€1.96
12.11.22
€0.000
12.11.23
-17.89%
26.11.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€6.75
14.11.22
€10.00
14.11.23
31.66%
17.11.22

Could be very worthwhile Investment >20% year
Very capable Management
Very good company culture
Few uniques
buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€0.30
12.11.21
€0.50
12.11.22
-78.55%
13.11.22

Could be worthwhile Investment >10% per year
buy
Crossject S.A.

Start price
Target price
Perf. (%)
€4.71
16.08.22
€5.00
16.08.23
-14.13%
12.11.22

Could be worthwhile Investment >10% per year
buy
Nanorepro AG

Start price
Target price
Perf. (%)
€9.30
09.11.21
-
09.11.22
-72.37%
10.11.22

Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€6.20
19.09.22
-
19.09.23
-18.43%
08.11.22

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
buy
Mauna Kea Tech

Start price
Target price
Perf. (%)
€0.84
07.11.21
€1.10
07.11.22
-33.61%
08.11.22

Could be worthwhile Investment >10% per year
CytoTools AG

Start price
Target price
Perf. (%)
€8.50
01.11.21
-
01.11.22
-78.94%
02.11.22

Probably not worthwhile Investment
First Wave BioPharma Inc.

Start price
Target price
Perf. (%)
€8.22
15.10.22
€0.000
15.10.23
2.13%
29.10.22

Low dividend yield expected
Bad rating
ROE lower than 10% per year
Sustainability is little important
buy
Euromedis Groupe

Start price
Target price
Perf. (%)
€4.10
04.10.22
-
04.10.23
14.15%
25.10.22

Probably not worthwhile Investment
buy
aTyr Pharma Inc

Start price
Target price
Perf. (%)
€2.68
27.06.22
-
27.06.23
-12.04%
23.10.22

Could be worthwhile Investment >10% per year
Genoway S.A. Inh.

Start price
Target price
Perf. (%)
€4.37
07.11.21
€4.10
07.11.22
-19.68%
22.10.22

Could be worthwhile Investment >10% per year
buy
Biosynex

Start price
Target price
Perf. (%)
€15.66
20.10.21
€17.00
20.10.22
-21.52%
21.10.22

Could be worthwhile Investment >10% per year
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€6.61
29.08.22
-
29.08.23
-10.43%
15.10.22

Could be very worthwhile Investment >20% year
buy
iBio Inc.

Start price
Target price
Perf. (%)
€6.24
03.08.22
€5.00
03.08.23
-75.96%
13.10.22

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products